The U.S. Food and Drug Administration (FDA) recently granted approval to pharmaceutical company Evita Solutions to sell its generic, lower-cost version of mifepristone — a pill used to end early pregnancies — prompting backlash from conservative, anti-abortion groups and politicians. Nearly every Republican senator signed a letter urging the FDA and the Department of Health and Human ...
Source